analysis

Strides Pharma Science Ltd.

NSE: STAR

BSE: 532531

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,126.80+0.4 (+0.04%)

3 Jul, 3:30 PM

Overview Analysis

Statements Technicals Forecast Peers Resources News

Summary Recommendation

A summary recommendation on the stock based on our classification and scoring techniques along with analyst recommendations.

StyleBox^TMWhat is StyleBox?

Market angel

The stock is high on quality and momentum, not the cheapest but still favoured. A potential buy.

Detail >

QVM scoreWhat is QVM score?

89.3 / 100

The stock has high QVM score with respect to other stocks in the market. Bullish.

Analyst ratingWhat is Analyst rating?

No active sell-side coverage. Recommendations not available.

Technical indicatorsSee all >

74 %

Strides Pharma Science Ltd. on 1D timeframe is bullish for 17 out of 23 technical oscillators and moving averages.

Ratios and Statistics

A look at some key ratios and statistics for the stock. Change tabs to find the relevant ratios. Click on chart icon to view historical analysis of a particular ratio.

	2025 Jul 31	2025 Aug 31	2025 Sept 30	2025 Oct 31	2025 Nov 30	2025 Dec 31	2026 Jan 31	2026 Feb 28	2026 Mar 31	2026 Apr 30	2026 May 31	2026 Jun 30	2026 Jul 03
Multiples
P/E (TTM)	22.20	21.93	20.89	23.75	20.38	20.91	20.35	15.20	16.74	18.51	18.42	18.11	18.67
P/B (latest)	3.16	3.12	2.97	3.38	2.94	3.01	2.93	2.85	3.14	3.47	3.30	3.24	3.34
P/S (TTM)	1.73	1.71	1.63	1.85	1.73	1.77	1.73	1.66	1.83	2.02	2.11	2.07	2.14
CAPE (3Y)	110.50	109.16	104.00	118.22	71.04	72.89	70.95	37.62	41.44	45.82	36.79	36.16	37.27
CAPE (5Y)	-	-	-	-	-	-	-	-	-	-	374.66	368.29	379.58
P/E (1Y Forward)	16.17	15.98	13.73	15.26	13.56	13.66	13.06	12.57	13.75	15.20	15.13	14.33	14.72
P/S (1Y Forward)	1.58	1.56	1.41	1.59	1.51	1.53	1.47	1.40	1.52	1.68	1.70	1.64	1.69
Yields (%)
Book to Market	0.32	0.32	0.34	0.30	0.34	0.33	0.34	0.35	0.32	0.29	0.30	0.31	0.30
Earnings yield	4.51%	4.56%	4.79%	4.21%	4.91%	4.78%	4.91%	6.58%	5.97%	5.40%	5.43%	5.52%	5.36%
Operating CF yield	-33.90%	-34.31%	-36.01%	-31.68%	6.33%	6.17%	6.34%	6.53%	5.93%	5.37%	5.26%	5.35%	5.19%
FCFE yield	-41.37%	-41.87%	-43.95%	-38.66%	-41.16%	-40.11%	-41.21%	-42.47%	-38.56%	-34.87%	-1.18%	-1.20%	-1.17%
FCFF yield	-29.23%	-29.53%	-30.75%	-27.60%	-29.37%	-28.73%	-29.40%	-30.16%	-27.77%	-25.46%	2.13%	2.16%	2.11%

Historical Performance

Performance with respect to benchmark. Prices are adjusted for splits, bonus and rights issue.

Show dividend adjusted performance

NIFTY50

NIFTYPHARMA

Add benchmark

Note: Prices are adjusted for splits, bonus and rights issue.

Showing:

Performance summary

	STAR	NIFTY50	NIFTYPHARMA

Start Period	01 Jan 2021	01 Jan 2021	01 Jan 2021
End Period	03 Jul 2026	03 Jul 2026	03 Jul 2026
Cumulative Return	192.06%	73.13%	98.01%
CAGR	21.53%	10.5%	13.24%
Volatility (ann.)	42.07%	14.24%	15.68%
Max Drawdown	-72.64%	-17.23%	-21.71%
RoMaD	0.3%	0.61%	0.61%
Sharpe	0.59	0.51	0.64
Sortino	0.92	0.72	0.93
Sortino/√2	0.65	0.51	0.65

Style Analysis

Learn more about stock scores

Scores on value, momentum and quality parameters. Change tabs to compare across market, sector, industry.

Value score

47.4 / 100

–

Strides Pharma Science Ltd. is reasonably valued relative to other stocks in the market

What is Value score?

Momentum score

87.8 / 100

↑

Strides Pharma Science Ltd. has high momentum relative to other stocks in the market

What is Momentum score?

Quality score

76.8 / 100

↑

Strides Pharma Science Ltd. has high quality relative to other stocks in the market

What is Quality score?

QVM score

89.3 / 100

↑

Strides Pharma Science Ltd. has high QVM score with respect to other stocks in the market

What is QVM score?

Scorecard

How to read Scorecard?

A comprehensive scorecard to compare Strides Pharma Science Ltd. on all metrics with other stocks. Access both rank and scores.

	Value	Market (All Stocks in NSE)	Sector (Healthcare)	Industry Group (Pharmaceuticals & Biotechnology)	Industry (Pharmaceuticals)
Size and Listing
Days since Listing	9,647.00
Enterprise value	11,730 Cr
Market Cap	10,382 Cr
Liquidity
Avg daily turnover 1M	23 Cr
Avg daily volume 1M	2,16,439
Avg daily turnover 3M	34 Cr
Avg daily volume 3M	3,15,601
Bid Ask Spread	0.89%
Delivery Percentage	43.87%
Volume surge ratio	0.70
Ownership
DII Holding %	13.11%
QoQ change DII holding %	1.46%
FII Holding %	28.68%
QoQ change FII holding %	-0.84%
QoQ change Gov holding %	0.00%
Promoter holding %	27.91%
QoQ change Promoter holding %	0.05%
Promoter pledged %	27.27%
Retail Holding %	24.98%
QoQ change Retail holding %	-0.64%

Checklist

What is Checklist?

Analyse how the stock fares on some investment checklists created by legendary investors and gurus. Also, build your own custom checklist.

O'Shaughnessy Tiny Titans

Benjamin Graham's Value

Piotroski F-Score

Dreman contrarian value

Peter Lynch Growth/Value

O'Shaugnessy Value

Templeton Growth/Value

Warren Buffet’s Consistent Compounders

John Neff’s contrarian value

Richard Driehaus Momentum Strategy

O'Shaughnessy Tiny Titans

Created by the famous investor James O'Shaugnessy, this screen/checklist aims to find out small-cap stocks with significant growth potential. We look for companies with market capitalization between Rs 500 cr and Rs 1500 cr that are reasonable valued and are in the top 25 percentile momentum as measured by Momentum score.

60.0 / 100

Strides Pharma Science Ltd. passes 3 out of 5 of this checklist's rules

Hits

Market Cap is greater than ₹500 crore

One Year Rel Return is greater than 0%

Stock is in top 25.0 percentile, sorted by Price Momentum score in descending order

Misses

Market Cap is less than ₹1500 crore

PS TTM is less than 1

Frequently Asked Questions

What is the PB ratio of Strides Pharma Science Ltd.?

The Price-to-Book (PB) ratio of Strides Pharma Science Ltd. is 3.34. It compares the stock's market price to its book value per share.

What is the EV/EBITDA of Strides Pharma Science Ltd.?

The EV/EBITDA of Strides Pharma Science Ltd. is 12.68. This ratio is used to assess the overall value of a company relative to its earnings before interest, taxes, depreciation and amortisation.

What is the debt-to-equity ratio of Strides Pharma Science Ltd.?

The debt-to-equity (D/E) ratio of Strides Pharma Science Ltd. is 0.57. The interest coverage ratio stands at 4.05x, reflecting the company's capacity to service its debt from operating earnings. A lower D/E ratio generally indicates a more financially stable company with less leverage.

What is the promoter holding in Strides Pharma Science Ltd.?

Promoters hold 27.91% of Strides Pharma Science Ltd. shares as per the latest quarterly shareholding disclosure, of which 27.27% is pledged — a higher pledged percentage warrants caution as it can be a governance risk signal.

What is the operating profit margin of Strides Pharma Science Ltd.?

The operating profit margin of Strides Pharma Science Ltd. is 14.88%, reflecting how much profit the company earns from its core operations relative to revenue.

What is the net profit margin of Strides Pharma Science Ltd.?

The net profit margin of Strides Pharma Science Ltd. is 11.45%, indicating the percentage of revenue that remains as profit after all expenses.

What is the Sharpely score for Strides Pharma Science Ltd.?

On Sharpely's proprietary scoring system, Strides Pharma Science Ltd. has a Quality Score of 76.8/100, Value Score of 47.1/100 and Price Momentum Score of 87.5/100, with an overall QVM Score of 89.3/100. The quality rating is high, value is moderate and price momentum is high. Visit the Scorecard and Checklist sections on the Analysis tab for a full breakdown.